Predilife S.A. (ALPRE.PA)

5.82 €

-0.14 (-2.35%)
Rating:
Recommendation:
-
Symbol ALPRE.PA
Price 5.82 €
Beta 0.293
Volume Avg. 0.00M
Market Cap 21.218M
Shares () -
52 Week Range 5.15-7.3
1y Target Est -
DCF Unlevered ALPRE.PA DCF ->
DCF Levered ALPRE.PA LDCF ->
ROE 443.60% Strong Buy
ROA -54.71% Strong Sell
Operating Margin -
Debt / Equity -353.29% Strong Sell
P/E -
P/B -10.97 Strong Sell
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Stephane Ragusa
Healthcare
Diagnostics & Research
Paris

Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.